Cargando…

Long term outcome and clinical experience on immune tolerance induction therapies in infantile Pompe disease

Detalles Bibliográficos
Autores principales:	Austin, Stephanie, Kishnani, Priya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667131/ http://dx.doi.org/10.1186/1471-2474-14-S2-O8

Ejemplares similares

Benefits of Prophylactic Short-Course Immune Tolerance Induction in Patients With Infantile Pompe Disease: Demonstration of Long-Term Safety and Efficacy in an Expanded Cohort
por: Desai, Ankit K., et al.
Publicado: (2020)

Pompe disease- experience from South India
por: Lingappa, Lokesh, et al.
Publicado: (2013)

Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy
por: Prater, Sean N, et al.
Publicado: (2013)

Immune tolerance strategies in siblings with infantile Pompe disease — Advantages for a preemptive approach to high-sustained antibody titers
por: Stenger, Elizabeth O., et al.
Publicado: (2015)

Transforming the clinical outcome in CRIM-negative infantile Pompe disease identified via Newborn Screening: The benefits of early treatment with enzyme replacement therapy and immune tolerance induction
por: Li, Cindy, et al.
Publicado: (2021)

Clinical laboratory experience of blood CRIM testing in infantile Pompe disease
por: Bali, Deeksha S., et al.
Publicado: (2015)

Pregnancy in Pompe disease
por: Plöckinger, Ursula
Publicado: (2013)

Cognitive outcome of classic infantile Pompe patients receiving enzyme therapy
por: Ebbink, BJ, et al.
Publicado: (2013)

Adenotonsillectomy should be avoided whenever possible in infantile-onset Pompe disease
por: Jones, Harrison N., et al.
Publicado: (2020)

Alglucosidase alfa: 5 years of experience in late-onset Pompe disease
por: Schoser, Benedikt
Publicado: (2013)

Characterization of immune response in Cross-Reactive Immunological Material (CRIM)-positive infantile Pompe disease patients treated with enzyme replacement therapy
por: Desai, Ankit K., et al.
Publicado: (2019)

Limitations of muscle biopsy in Pompe disease
por: Vissing, John
Publicado: (2013)

Pregnancy Outcomes in Late Onset Pompe Disease
por: Goker-Alpan, Ozlem, et al.
Publicado: (2020)

Immune Tolerance-Adjusted Personalized Immunogenicity Prediction for Pompe Disease
por: De Groot, Anne S., et al.
Publicado: (2021)

Behavioral, social and school functioning in children with Pompe disease
por: Korlimarla, Aditi, et al.
Publicado: (2020)

Advances in imaging for the diagnosis and disease monitoring of Pompe disease
por: Carlier, Robert-Yves
Publicado: (2013)

Reimbursement of orphan drugs: the Pompe and Fabry case in the Netherlands
por: van den Brink, Rinke
Publicado: (2014)

The Pompe Registry: tracking Pompe disease symptoms in a broad patient population
por: Byrne, B, et al.
Publicado: (2008)

CRIM-negative infantile Pompe disease: Characterization of immune responses in patients treated with ERT monotherapy
por: Berrier, Kathryn L., et al.
Publicado: (2015)

A favorable outcome in an infantile-onset Pompe patient with cross reactive immunological material (CRIM) negative disease with high dose enzyme replacement therapy and adjusted immunomodulation
por: Curelaru, Shiri, et al.
Publicado: (2022)

A Race Against Time—Changing the Natural History of CRIM Negative Infantile Pompe Disease
por: Gupta, Punita, et al.
Publicado: (2020)

An immune tolerance approach using transient low-dose methotrexate in the ERT-naïve setting of patients treated with a therapeutic protein: experience in infantile-onset Pompe disease
por: Kazi, Zoheb B., et al.
Publicado: (2018)

Antibody formation to enzyme therapy in classic infantile Pompe disease: implications of patient age
por: van Gelder, C, et al.
Publicado: (2013)

A pilot study on using rapamycin-carrying synthetic vaccine particles (SVP) in conjunction with enzyme replacement therapy to induce immune tolerance in Pompe disease
por: Lim, Han-Hyuk, et al.
Publicado: (2017)

Long term outcome in children with shunted hydrocephalus
por: Mashhadinezhad, Hosein
Publicado: (2012)

The Outcome of Infantile Onset Pompe Disease in South of Iran
por: Moravej, Hossein, et al.
Publicado: (2016)

Orofacial features and pediatric dentistry in the long-term management of Infantile Pompe Disease children
por: Galeotti, Angela, et al.
Publicado: (2020)

12.3 Long-term follow up of patients with CINCA syndrome: efficacy and tolerability of Anakinra treatment
por: Paloni, G, et al.
Publicado: (2008)

Development of a disease severity scoring system for patients with Pompe disease
por: Giannini, E, et al.
Publicado: (2008)

Use of the patient-reported outcomes measurement information system (PROMIS®) to assess late-onset Pompe disease severity
por: Harfouche, Melodi, et al.
Publicado: (2020)

Enzyme therapy and immune response in relation to CRIM status: the Dutch experience in classic infantile Pompe disease
por: van Gelder, Carin M., et al.
Publicado: (2014)

Small-Fiber Neuropathy in Pompe Disease: First Reported Cases and Prospective Screening of a Clinic Cohort
por: Hobson-Webb, Lisa D., et al.
Publicado: (2015)

The treatment of adolescent idiopathic scoliosis with Cheneau brace: long term outcome
por: Cinnella, P, et al.
Publicado: (2009)

Long-term outcome in childhood hydrocephalus: a comparison of child and parental perceptions of health outcome
por: Kulkarni, Abhaya V, et al.
Publicado: (2006)

Long term clinical history of an Italian cohort of infantile onset Pompe disease treated with enzyme replacement therapy
por: Parini, Rossella, et al.
Publicado: (2018)

Non-depleting anti-CD4 monoclonal antibody induces immune tolerance to ERT in a murine model of Pompe disease
por: Sun, Baodong, et al.
Publicado: (2014)

Long-term outcome after Boston brace treatment in adolescent idiopatic scoliosis
por: Lange, JE, et al.
Publicado: (2009)

Long-term education and employment outcomes in pediatric-onset systemic lupus erythematosus
por: Lawson, Erica F, et al.
Publicado: (2012)

Primary cardiac tumours in infants and children: surgical strategy and long-term outcome
por: Delmo Walter, E, et al.
Publicado: (2013)

Surgical treatment for bronhial carcinoid tumors prognostic factors for long-term outcome
por: Petrov, D, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rup78jtphaa8bjsihifip3g9ue